JP2017506747A - 妊孕性・妊娠監視装置及び方法 - Google Patents
妊孕性・妊娠監視装置及び方法 Download PDFInfo
- Publication number
- JP2017506747A JP2017506747A JP2016552344A JP2016552344A JP2017506747A JP 2017506747 A JP2017506747 A JP 2017506747A JP 2016552344 A JP2016552344 A JP 2016552344A JP 2016552344 A JP2016552344 A JP 2016552344A JP 2017506747 A JP2017506747 A JP 2017506747A
- Authority
- JP
- Japan
- Prior art keywords
- pregnancy
- sample
- hcg
- fertility
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000035935 pregnancy Effects 0.000 title claims abstract description 103
- 238000000034 method Methods 0.000 title claims abstract description 26
- 230000035558 fertility Effects 0.000 title claims description 32
- 238000012806 monitoring device Methods 0.000 title claims description 26
- 230000016087 ovulation Effects 0.000 claims abstract description 43
- 201000003511 ectopic pregnancy Diseases 0.000 claims abstract description 36
- 238000005259 measurement Methods 0.000 claims abstract description 25
- 208000034702 Multiple pregnancies Diseases 0.000 claims abstract description 20
- 208000000995 spontaneous abortion Diseases 0.000 claims abstract description 20
- 206010000234 Abortion spontaneous Diseases 0.000 claims abstract description 17
- 239000007788 liquid Substances 0.000 claims abstract description 17
- 208000015994 miscarriage Diseases 0.000 claims abstract description 17
- 238000012544 monitoring process Methods 0.000 claims abstract description 17
- 238000004458 analytical method Methods 0.000 claims abstract description 11
- 238000004364 calculation method Methods 0.000 claims abstract description 4
- 102000011022 Chorionic Gonadotropin Human genes 0.000 claims description 108
- 108010062540 Chorionic Gonadotropin Proteins 0.000 claims description 108
- 229940084986 human chorionic gonadotropin Drugs 0.000 claims description 108
- 239000000523 sample Substances 0.000 claims description 96
- 102000009151 Luteinizing Hormone Human genes 0.000 claims description 74
- 108010073521 Luteinizing Hormone Proteins 0.000 claims description 74
- 229940040129 luteinizing hormone Drugs 0.000 claims description 74
- 239000012472 biological sample Substances 0.000 claims description 23
- 230000008859 change Effects 0.000 claims description 23
- 229940088597 hormone Drugs 0.000 claims description 23
- 239000005556 hormone Substances 0.000 claims description 23
- 239000013060 biological fluid Substances 0.000 claims description 17
- 230000004720 fertilization Effects 0.000 claims description 12
- 230000003862 health status Effects 0.000 claims description 11
- 230000036541 health Effects 0.000 claims description 9
- 210000002700 urine Anatomy 0.000 claims description 8
- 230000002159 abnormal effect Effects 0.000 claims description 7
- 230000002745 absorbent Effects 0.000 claims description 7
- 239000002250 absorbent Substances 0.000 claims description 7
- 230000003287 optical effect Effects 0.000 claims description 7
- 210000004369 blood Anatomy 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- 230000027758 ovulation cycle Effects 0.000 claims description 5
- 230000027939 micturition Effects 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 238000000862 absorption spectrum Methods 0.000 claims description 3
- 238000004891 communication Methods 0.000 claims description 3
- 229920001940 conductive polymer Polymers 0.000 claims description 3
- 210000003722 extracellular fluid Anatomy 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 239000002923 metal particle Substances 0.000 claims description 3
- 210000002381 plasma Anatomy 0.000 claims description 3
- 210000003296 saliva Anatomy 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 claims description 3
- 238000000411 transmission spectrum Methods 0.000 claims description 3
- 206010000210 abortion Diseases 0.000 claims description 2
- 231100000176 abortion Toxicity 0.000 claims description 2
- 238000010521 absorption reaction Methods 0.000 claims 1
- 238000000840 electrochemical analysis Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 4
- 238000012360 testing method Methods 0.000 description 38
- 235000013601 eggs Nutrition 0.000 description 23
- 102000002322 Egg Proteins Human genes 0.000 description 7
- 108010000912 Egg Proteins Proteins 0.000 description 7
- 208000032843 Hemorrhage Diseases 0.000 description 7
- 208000034158 bleeding Diseases 0.000 description 7
- 230000000740 bleeding effect Effects 0.000 description 7
- 210000004681 ovum Anatomy 0.000 description 7
- 210000003754 fetus Anatomy 0.000 description 6
- 210000003101 oviduct Anatomy 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 5
- 210000004291 uterus Anatomy 0.000 description 5
- 230000003211 malignant effect Effects 0.000 description 4
- 230000002175 menstrual effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000001568 sexual effect Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 2
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 2
- 210000004081 cilia Anatomy 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000003821 menstrual periods Effects 0.000 description 2
- 229960000485 methotrexate Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000036266 weeks of gestation Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 208000013440 Complete hydatidiform mole Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000036830 Normal foetus Diseases 0.000 description 1
- 208000013438 Partial hydatidiform mole Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 208000024776 abnormal vaginal bleeding Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 150000001875 compounds Chemical group 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 208000004104 gestational diabetes Diseases 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 208000037805 labour Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 238000005424 photoluminescence Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 201000011461 pre-eclampsia Diseases 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 238000013102 re-test Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 208000002254 stillbirth Diseases 0.000 description 1
- 231100000537 stillbirth Toxicity 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000002993 trophoblast Anatomy 0.000 description 1
- 230000001573 trophoblastic effect Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48785—Electrical and electronic details of measuring devices for physical analysis of liquid biological material not specific to a particular test method, e.g. user interface or power supply
- G01N33/48792—Data management, e.g. communication with processing unit
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N2021/7756—Sensor type
- G01N2021/7759—Dipstick; Test strip
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N2021/7793—Sensor comprising plural indicators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Reproductive Health (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Medical Informatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Optics & Photonics (AREA)
- Human Computer Interaction (AREA)
- Databases & Information Systems (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Public Health (AREA)
- Plasma & Fusion (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
前記生体の液体サンプルの一部を吸収したサンプル吸収部材を受け入れるように構成されているサンプルホルダと、
分析装置と、
表示手段と、を備えており、
前記分析装置は、前記生体の液体サンプル中に存在する黄体形成ホルモン(LH)の量を示すパラメータを測定するとともに、前記生体の液体サンプル中のヒト絨毛膜性生殖腺刺激ホルモン(hCG)の量を示すパラメータを測定することによって、前記サンプルホルダ内の前記サンプル吸収部材を分析するように構成されており、前記分析装置は、更に、電子計算手段を備えており、
前記計算手段は、複数の連続的なサンプル吸収部材からの複数の測定値を算出・記録し、且つ、前記生体の液体サンプル中のLHの測定量の所定の増加を識別して、排卵日及び/又は排卵時を特定する一方、また、前記生体の液体サンプル中のhCGの測定量を識別・記録するように構成されており、ここで、所定の値に対するhCGの測定量の偏差は、異常妊娠を示すものと判断され、妊娠の健康状態の表示は、前記表示手段に表示される。
1組の時間差を設けた連続的な生体の液体サンプルを取得するステップと、
前記生体の液体サンプル中のLHの量を示すパラメータを測定するステップと、
LHの量の所定の変化の存在を判定し、排卵日を対応する測定日に特定するステップと、
前記サンプル中のhCGの量を示すパラメータを測定するステップと、
各連続的な生体の液体サンプル中のhCGの測定量の変化を判定し、測定したhCGの相対的な変化を算出するステップと、
hCGの測定量の相対的な変化が、排卵日に対して、所定の値からずれているかどうかを判定するステップと、
測定したhCGが、所定の値以内の場合、健康状態の結果を返すステップ、又は、
測定したhCGが、所定の値からずれている場合、警告を返すステップと、を含んでいる。
第1の態様による妊孕性・妊娠監視装置と、
サンプル吸収部材と、を備えている。
4 サンプルホルダ
6 ディスプレイ
10 制御ボタン
24 OLED
25 プロセッサ
26 USBコネクタ
30 クレードル
40 上側収容部
42 下側収容部
50 サンプル吸収部材/検査ストリップ
102 装置
104 サンプルホルダ
106 ディスプレイ
110,112 制御部
150 サンプル吸収部材
Claims (21)
- 生体の液体サンプル中のホルモンを検出・監視するための妊孕性・妊娠監視装置であって、前記装置は、
前記生体の液体サンプルの一部を吸収したサンプル吸収部材を受け入れるように構成されているサンプルホルダと、
分析装置と、
表示手段と、を備えており、
前記分析装置は、前記生体の液体サンプル中に存在する黄体形成ホルモン(LH)の量を示すパラメータを測定するとともに、前記生体の液体サンプル中のヒト絨毛膜性生殖腺刺激ホルモン(hCG)の量を示すパラメータを測定することによって、前記サンプルホルダ内の前記サンプル吸収部材を分析するように構成されており、前記分析装置は、更に、電子計算手段を備えており、
前記計算手段は、複数の連続的なサンプル吸収部材からの複数の測定値を算出・記録し、且つ、前記生体の液体サンプル中のLHの測定量の所定の増加を識別して、排卵日を特定する一方、また、前記生体の液体サンプル中のhCGの測定量を識別・記録するように構成されており、ここで、所定の値に対するhCGの測定量の偏差は、異常妊娠を示すものと判断され、妊娠の健康状態の表示は、前記表示手段に表示されることを特徴とする妊孕性・妊娠監視装置。 - 前記分析装置は、前記サンプル吸収部材又は前記生体の液体サンプルの色、pH、透過スペクトル、又は吸収スペクトルなどのいくつかの測定可能なパラメータを分析するように構成されていることを特徴とする、請求項1に記載の妊孕性・妊娠監視装置。
- 前記分析装置は、前記サンプル吸収部材又は前記生体の液体サンプルの色の変化を識別するようになっている光学分析装置であることを特徴とする、請求項1又は2に記載の妊孕性・妊娠監視装置。
- 前記分析装置は、前記サンプル吸収部材又は前記生体の液体サンプルのpHレベルを識別することができるpH分析装置であることを特徴とする、請求項1又は2に記載の妊孕性・妊娠監視装置。
- 前記分析装置は、イオン選択性電極と結合されていて、前記サンプル吸収部材又は前記生体の液体サンプルのpH濃度又は塩濃度を識別することができるか、又は前記サンプル吸収部材内の電気活性標識を識別することができる電気化学分析装置であることを特徴とする、請求項1又は2に記載の妊孕性・妊娠監視装置。
- 前記電気活性標識は、金属粒子標識、導電性高分子標識、又は酵素標識であることを特徴とする、請求項5に記載の妊孕性・妊娠監視装置。
- 更に、前記妊孕性・妊娠監視装置を外部装置に接続するための接続手段を備えていることを特徴とする、請求項1乃至6のいずれか一項に記載の妊孕性・妊娠監視装置。
- 更に、外部装置と無線通信するための通信手段を備えていることを特徴とする、請求項1乃至7のいずれか一項に記載の妊孕性・妊娠監視装置。
- 前記サンプル吸収部材は、排尿途中の尿サンプル、血漿又は血清などの血液系サンプル、間質液サンプル、唾液サンプル、又は歯肉液サンプルから選択される生体サンプルを吸収するように構成されていることを特徴とする、請求項1乃至8のいずれか一項に記載の妊孕性・妊娠監視装置。
- 更に、いくつかの所定の閾値を示すように構成されているアラームを備えていることを特徴とする、請求項1乃至9のいずれか一項に記載の妊孕性・妊娠監視装置。
- 前記妊孕性・妊娠監視装置は、排卵日及び/又は排卵時を示すLHの所定の増加を識別するため、いくつかの月経周期にわたって、前記生体の液体サンプル中に存在するLHの量を示すパラメータを測定することを特徴とする、請求項1乃至10のいずれか一項に記載の妊孕性・妊娠監視装置。
- 前記妊孕性・妊娠監視装置は、卵子受精日及び/又は卵子受精時を識別するように構成されていることを特徴とする、請求項1乃至11のいずれか一項に記載の妊孕性・妊娠監視装置。
- 前記妊娠の健康状態の表示は、使用者が連続的な生体サンプルをサンプル吸収部材に挿入すべき時、使用者が医者を訪問すべき時、測定値が不正確と思われる時などの情報を含んでいることを特徴とする、請求項1乃至12のいずれか一項に記載の妊孕性・妊娠監視装置。
- 正常妊娠、子宮外妊娠、多胎妊娠、又は流産の危険の増加を識別するための生体の液体サンプル中のホルモンを検出・監視するための方法であって、前記方法は、
1組の時間差を設けた連続的な生体の液体サンプルを取得するステップと、
前記生体の液体サンプル中のLHの量を示すパラメータを測定するステップと、
LHの量の所定の変化の存在を判定し、排卵日を対応する測定日に特定するステップと、
前記サンプル中のhCGの量を示すパラメータを測定するステップと、
各連続的な生体の液体サンプル中のhCGの測定量の変化を判定し、測定したhCGの相対的な変化を算出するステップと、
hCGの測定量の相対的な変化が、排卵日に対して、所定の値からずれているかどうかを判定するステップと、
測定したhCGが、所定の値以内の場合、健康状態の結果を返すステップ、又は、
測定したhCGが、所定の値からずれている場合、警告を返すステップと、を含んでいることを特徴とする方法。 - 測定したhCGが、排卵日に対して、所定の値未満である場合、子宮外/流産の結果を返すことができ、前記子宮外/流産の結果は、子宮外妊娠の可能性又は流産の可能性を示していることを特徴とする、請求項14に記載の方法。
- 測定したhCGが、排卵日に対して、所定の値を超える場合、多胎の結果を返すことができ、前記多胎の結果は、多胎妊娠の可能性を示していることを特徴とする、請求項14に記載の方法。
- 前記生体の液体サンプル中のLHの量を示すパラメータは、排卵日後の約5〜7日間、監視及び分析して、妊娠の健康状態を示すことができることを特徴とする、請求項14乃至16のいずれか一項に記載の方法。
- 前記健康状態の結果は、LHの測定量、hCGの測定量、検査の日時、及び時間差を設けた連続的な検査間の時間量のいずれかを含んでいる情報を含んでいることを特徴とする、請求項14乃至17のいずれか一項に記載の方法。
- 前記警告は、LHの測定量、hCGの測定量、検査の日時、時間差を設けた連続的な検査間の時間量、再検査の要求、及び医者を訪問するようにとの勧告のいずれかを含んでいる情報を含んでいることを特徴とする、請求項14乃至18のいずれか一項に記載の方法。
- 請求項1に記載の妊孕性・妊娠監視装置と、
サンプル吸収部材と、を備えていることを特徴とするパーツキット。 - LHの量を示すパラメータを測定するための第1のサンプル吸収部材及びhCGの量を示すパラメータを測定するための第2のサンプル吸収部材の使用法であって、前記第1及び第2のサンプル吸収部材は、請求項1に記載の妊娠監視装置に挿入されることを特徴とする使用法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1402668.6 | 2014-02-14 | ||
GB201402668A GB201402668D0 (en) | 2014-02-14 | 2014-02-14 | Fertility and pregnancy monitoring device and method |
PCT/GB2015/050402 WO2015121661A1 (en) | 2014-02-14 | 2015-02-13 | Fertility and pregnancy monitoring device and method |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2017506747A true JP2017506747A (ja) | 2017-03-09 |
Family
ID=50440200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016552344A Pending JP2017506747A (ja) | 2014-02-14 | 2015-02-13 | 妊孕性・妊娠監視装置及び方法 |
Country Status (9)
Country | Link |
---|---|
US (1) | US20170052193A1 (ja) |
EP (1) | EP3105595A1 (ja) |
JP (1) | JP2017506747A (ja) |
CN (1) | CN105980860A (ja) |
AU (1) | AU2015216706A1 (ja) |
CA (1) | CA2938494A1 (ja) |
GB (2) | GB201402668D0 (ja) |
RU (1) | RU2016134617A (ja) |
WO (1) | WO2015121661A1 (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10890590B2 (en) | 2012-09-27 | 2021-01-12 | Ellume Limited | Diagnostic devices and methods |
GB201402668D0 (en) * | 2014-02-14 | 2014-04-02 | Concepta Diagnostics Ltd | Fertility and pregnancy monitoring device and method |
EP3248001B1 (en) * | 2015-01-22 | 2019-09-18 | Ellume Pty Ltd. | Diagnostic devices and methods for mitigating hook effect and use thereof |
KR101797461B1 (ko) | 2016-09-29 | 2017-11-15 | 전자부품연구원 | 바이오 메디컬 광화학 센서 및 그 제조방법 |
US20190120828A1 (en) * | 2016-10-27 | 2019-04-25 | Angela Renee Crumitie | Pregnancy test and keepsake device and method of use thereof |
CN108122602B (zh) * | 2016-11-29 | 2021-11-23 | 网易(杭州)网络有限公司 | 基于电子设备的数据分析方法、数据分析装置 |
GB201817729D0 (en) | 2018-10-30 | 2018-12-19 | Concepta Diagnostics Ltd | Personal home health testing |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60501271A (ja) * | 1983-05-06 | 1985-08-08 | ザ・トラステイ−ズ・オブ・コロンビア・ユニヴア−シテイ・イン・ザ・シテイ・オブ・ニユ−・ヨ−ク | ヒト絨毛性ゴナドトロピンのイムノアツセイ |
JPH10288581A (ja) * | 1997-04-15 | 1998-10-27 | Nissho Corp | 診断薬用測定装置 |
JP2005037278A (ja) * | 2003-07-16 | 2005-02-10 | Matsushita Electric Ind Co Ltd | 健康管理システム |
WO2006100415A1 (en) * | 2005-03-24 | 2006-09-28 | Inverness Medical Switzerland Gmbh | Determining the estimated date of embryo implantation and related dates |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9217866D0 (en) * | 1992-08-21 | 1992-10-07 | Unilever Plc | Monitoring method |
US6886740B1 (en) * | 1999-06-15 | 2005-05-03 | Randall H Craig | Apparatus for calculating time periods |
EP2128604A1 (en) * | 2003-06-04 | 2009-12-02 | Inverness Medical Switzerland GmbH | Optical arrangement for assay reading device |
WO2007122403A1 (en) * | 2006-04-21 | 2007-11-01 | British Pregnancy Advisory Service | Device and method for detection of a pregnancy associated hormone |
GB0607964D0 (en) * | 2006-04-21 | 2006-05-31 | British Pregnancy Advisory Ser | Pregnancy testing kit |
US20100129935A1 (en) * | 2008-11-25 | 2010-05-27 | Sarah Daniel Maddison | Pregnancy testing method |
JP6400012B2 (ja) * | 2012-09-27 | 2018-10-03 | エリューム・ピーティーワイ・リミテッド | 診断装置および方法 |
GB201402668D0 (en) * | 2014-02-14 | 2014-04-02 | Concepta Diagnostics Ltd | Fertility and pregnancy monitoring device and method |
-
2014
- 2014-02-14 GB GB201402668A patent/GB201402668D0/en not_active Ceased
-
2015
- 2015-02-13 GB GB1502419.3A patent/GB2528520A/en not_active Withdrawn
- 2015-02-13 RU RU2016134617A patent/RU2016134617A/ru not_active Application Discontinuation
- 2015-02-13 EP EP15705069.1A patent/EP3105595A1/en not_active Withdrawn
- 2015-02-13 WO PCT/GB2015/050402 patent/WO2015121661A1/en active Application Filing
- 2015-02-13 CN CN201580008613.2A patent/CN105980860A/zh active Pending
- 2015-02-13 US US15/118,613 patent/US20170052193A1/en not_active Abandoned
- 2015-02-13 CA CA2938494A patent/CA2938494A1/en not_active Abandoned
- 2015-02-13 JP JP2016552344A patent/JP2017506747A/ja active Pending
- 2015-02-13 AU AU2015216706A patent/AU2015216706A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60501271A (ja) * | 1983-05-06 | 1985-08-08 | ザ・トラステイ−ズ・オブ・コロンビア・ユニヴア−シテイ・イン・ザ・シテイ・オブ・ニユ−・ヨ−ク | ヒト絨毛性ゴナドトロピンのイムノアツセイ |
JPH10288581A (ja) * | 1997-04-15 | 1998-10-27 | Nissho Corp | 診断薬用測定装置 |
JP2005037278A (ja) * | 2003-07-16 | 2005-02-10 | Matsushita Electric Ind Co Ltd | 健康管理システム |
WO2006100415A1 (en) * | 2005-03-24 | 2006-09-28 | Inverness Medical Switzerland Gmbh | Determining the estimated date of embryo implantation and related dates |
Also Published As
Publication number | Publication date |
---|---|
RU2016134617A3 (ja) | 2018-09-26 |
CN105980860A (zh) | 2016-09-28 |
WO2015121661A1 (en) | 2015-08-20 |
GB2528520A (en) | 2016-01-27 |
RU2016134617A (ru) | 2018-03-19 |
GB201402668D0 (en) | 2014-04-02 |
GB201502419D0 (en) | 2015-04-01 |
AU2015216706A1 (en) | 2016-08-18 |
CA2938494A1 (en) | 2015-08-20 |
US20170052193A1 (en) | 2017-02-23 |
EP3105595A1 (en) | 2016-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2017506747A (ja) | 妊孕性・妊娠監視装置及び方法 | |
Su et al. | Detection of ovulation, a review of currently available methods | |
Gaccioli et al. | Screening for fetal growth restriction using fetal biometry combined with maternal biomarkers | |
Morse et al. | Fetal growth screening by fundal height measurement | |
Condous et al. | Human chorionic gonadotrophin and progesterone levels in pregnancies of unknown location | |
US20140073879A1 (en) | System for monitoring pregnancy in mammals | |
Salama et al. | Reproducibility and reliability of automated volumetric measurement of single preovulatory follicles using SonoAVC | |
Moroz et al. | Rate of sonographic cervical shortening and biologic pathways of spontaneous preterm birth | |
AU2015353639B2 (en) | Determination of fertility potential from the oxidation-reduction potential of a biological sample | |
CN104380104A (zh) | 先兆子痫筛查法 | |
Urquhart et al. | Comparing time to diagnosis and treatment of patients with ruptured ectopic pregnancy based on type of ultrasound performed: a retrospective inquiry | |
US6364844B1 (en) | Diagnostic system for determining and/or monitoring physiological conditions in mammals | |
Hiew et al. | Clinical utility of plasma progesterone and blood and plasma glucose concentrations in predicting parturition in Holstein cows | |
JPH11133031A (ja) | 排卵をモニタリングするための方法、装置およびテストキット | |
JP6456394B2 (ja) | 胎児仮死の診断 | |
Canda et al. | Fetal nasal bone length as a novel marker for prediction of adverse perinatal outcomes in the first-trimester of pregnancy | |
Bonacquisto | Antenatal screening: the first and second trimester | |
CN113873953A (zh) | 体温检定 | |
KR102482468B1 (ko) | 조산에 대한 정보 제공 방법 및 이를 적용한 디바이스 | |
Ghafoor | Review of prelabor rupture of the membranes: pathophysiologic concepts and novel therapeutic strategies | |
Madiuw et al. | Health Technologies for Detecting High-Risk Conditions in Pregnancy: A | |
Yang et al. | the Forecast of Weekly β-HCG and Progesterone for Early Pregnancy | |
WO2018206701A1 (en) | Device for the determination of fertility status | |
Seifert-Klauss | POCT in obstetrics and gynecology | |
CN115206550A (zh) | 随访管理方法、装置、服务器及可读存储介质 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180117 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20181012 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20181023 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20181219 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20190702 |